|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 236 | Rational Approach for HVTN Phase I/II HIV Vaccine Trials
A. J. Rossini, S. G. Self*, M. Hudgens, and P. Gilbert Fred Hutchinson Cancer Res. Ctr., Seattle, WA, USA |
| 237 | Safety of Live Recombinant ALVAC-HIV (vCP1521) Priming with AIDSVAX B/E Boosting in Thai HIV-1-Negative Participants: Preliminary Results
S. Nitayaphan*1, P. Pitisuttithum2, P. Singharaj1, W. Heyward5, S. Gurunathan4, J. Kim3, A. Brown1, and the Thai AIDS Vaccine Evaluation Group 1Armed Forces Res. Inst. of Med. Sci., Bangkok, Thailand; 2Mahidol Univ., Bangkok, Thailand; 3Walter Reed Army Inst. of Res., Rockville, MD, USA; 4Aventis Pasteur, Lyon, France; and 5VaxGen, Brisbane, CA, USA |
| 238 | Analysis of Clinical Cellular Immune Response following Immunization with an HIV-1 DNA Vaccine
J. D. Boyer*1, C. Kang1, M. Lee1, K. Lacy1, J. Eldridge2, Z. Israel2, R. S. Ginsberg2, R. R. MacGregor1, and D. B. Weiner1 1Univ. of Pennsylvania Sch. of Med., Hosp. of the Univ. of Pennsylvania, Philadelphia, USA and 2Lederle Vaccine Inc., Pearl River, NY, USA |